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Nasopharyngeal carcinoma (NPC) is among the five most common malignancies in Malaysia. 
Most NPC patients are diagnosed at late stages of the disease which complicates the clinical 
management of the patients. Identification of new reliable biomarker is crucial to improve early 
diagnosis of NPC and increase the survival rate of patients. Recent study found that 
microRNAs (miRNAs), particularly miR-101, were involved in the tumorigenesis of head and 
neck cancer where NPC samples were included in the study. This study was conducted to 
observe the expression of miR-101 in NPC tumour tissues and compare its consistency with 
previous study as a step towards finding the new biomarker for NPC. The biopsy samples were 
obtained from hospitals and verified histologically using hematoxylin and eosin method for 
tissue classification. Total RNA was extracted from NPC tissues and normal nasopharyngeal 
epithelium tissues. The expression of miR-101 in NPC was quantified using quantitative 
polymerase chain reaction (qPCR) method. The differential expression of miR-101 in NPC as 
compared to normal nasopharyngeal epithelium tissues was analysed using 2-ΔΔCT calculation. 
The significance of the differential expression was analysed using SPSS software. Five samples 
have been verified as NPC and three samples were normal nasopharyngeal epithelium. The 
differential expression calculation found that miR-101 was downregulated in NPC as compared 
to normal nasopharyngeal epithelium tissues, which consistent with previous study. However, 
the differential expression was not significant. Therefore, our finding provides a preliminary 
result towards embarkment of a larger and comprehensive study. 
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INTRODUCTION 
 
The recent trend on the statistics of nasopharyngeal carcinoma 
(NPC) in Malaysia is quite worrying. This cancer has been 
categorized as the five most common malignancies in the country. 
According to the Malaysian National Cancer Registry Report for 
2007 until 2011 period, the ethnic Chinese had been affected the 
most, followed by the Malays and very rare among the Indians 
[1]. Most patients who suffered from this cancer have less than five-
year survival rate [1,2]. This might be due to late diagnosis of the 
cancer whereby most NPC patients are diagnosed at late stages of 
the disease [1 – 3]. Therefore, this might complicate the clinical 
management of the patients. Combination treatment by 
radiotherapy and chemotherapy is needed for the late stage NPC 
whereas only radiotherapy alone is needed for an early stage of the 
cancer [3]. Therefore, early detection is an important factor to 
decrease the burden of the patient and determine the chance of 
success in the treatment [4]. Nowadays, the available method for 
diagnosis of NPC only relies on biopsy and histological 
examinations, which is invasive and requires highly trained 
specialists [5]. In addition, there is no effective and feasible method 
for NPC screening available. Due to this fact, a molecular approach 
is suggested to enable the early detection of NPC which may be 
very helpful in improving diagnosis [6]. In a previous study by 
Nurul-Syakima et al. [6] found that miR-101 was down-regulated 
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in biopsies of head and neck cancer Malaysia patients where NPC 
biopsies were also included in the studied samples. Therefore, in 
the current study, we sought to observe the expression of miR-101 
in independent biopsy samples of Malaysia NPC patients as a 
preliminary study before embarking with a more comprehensive 
study. 
 
MATERIALS AND METHODS 
 
Subject recruitment 
 
The protocol was reviewed and approved by IIUM Research Ethic 
Committee (IREC 530) and Medical Research Ethic Committee 
(NMRR15-1976-27156). The subjects were recruited in two 
Pahang government hospitals, which were Hospital Tengku 
Ampuan Afzan, Kuantan and Hospital Sultan Haji Ahmad Shah, 
Temerloh. The consent informs have been obtained the subjects 
who fulfilled the inclusion and exclusion criteria of the study. The 
personal details of the subjects have been kept confidential and the 
names of subjects have been replaced with identification number. 
Based on the subject recruitment, five male patients who met the 
inclusion and exclusion criteria were recruited for sample 
collection. All the subjects have been briefed about the study and 
given with written informed consent. During the recruitment, 
demographic data have been taken from each patient. Table 1 
summarizes the demographic data of the patients. 
 
Table 1. Demographics of patients with nasopharyngeal carcinoma 
 
 
 
 
 
 
 
 
 
 
 
 
Biopsy sample collection 
 
The NPC tissues have been obtained from the patients who have 
been suspected for NPC during their visits to Ear, Nose and Throat 
Clinic of HTAA and HOSHAS. The tissue biopsies have been 
taken from the patients during the endoscopic procedure. The 
tumor tissues have been cut <0.5 cm in at least one dimension and 
the specimens were fixed using formalin immediately after the 
surgical removal. Normal tissues have been taken at >2 cm away 
from the tumor part or from the other side of the nasopharynx of 
the same patient [6]. The biopsy tissues have been put into 
formalin immediately after the dissection for fixation. The status 
of the tissues, either NPC tissue or normal nasopharyngeal 
epithelium tissues, have been verified by a pathologist through 
histopathological examination. The tissues have been labeled as 
“NN” for NPC tissues and “NC” for normal nasopharyngeal 
epithelium tissues. 
 
Histopathological examination 
 
After obtaining the formalin-fixed biopsy specimens, tissue 
processing was carried out using an automated tissue processor. 
The samples have been placed in the aqueous environment and 
taken through a series of dehydration using 50% alcohol for 1 
hour, 70% alcohol for 1 hour, 80% alcohol for 1 hour, 95% 
alcohol for 1 hour and two times in 100% alcohol for 2 hours. 
Finally, the samples have been cleared twice by clearing solvent, 
xylene for another 2 hours before the samples have been placed in 
molten wax to form formalin-fixed paraffin-embedded (FFPE) 
tissue blocks. Then, the blocks have been sectioned into 4 µm 
thickness sections using a rotary microtome, placed onto glass 
slides and stained using hematoxylin & eosin (H&E) method. 
Finally, histopathological examination was performed by a 
pathologist to verify the status of the tissues. 
 
Total RNA isolation 
 
The total RNA isolation from FFPE tissue samples have been 
conducted using innuPREP FFPE Total RNA Kit (Analytik Jena, 
Germany) according to the manufacturer’s protocol. 
Approximately six sections of 10 µm thickness in each of 300 mm² 
area or four sections of 10 µm thickness in each of 400 mm² of 
FFPE tissue samples have been used as starting material for total 
RNA isolation. The FFPE starting material was placed into a 1.5 
ml reaction tube and centrifuged at maximum speed for 1 minute 
to push the sample to the bottom of the tube. The sample was 
lysed using 400 µl Lysis Solution MA and 40 µl Proteinase K and 
mixed vigorously for 10 seconds. The reaction tube was incubated 
at 65°C for 30 minutes and vortexed 4 times during the incubation 
period. After lysis step, the sample was centrifuged at maximum 
speed for 3 minutes. Then, the supernatant was transferred into 
a new 1.5 ml reaction tube. The procedure was repeated with 
incubation at 80°C for 30 minutes. Then, the supernatant was 
transferred into a new 1.5 ml reaction tube. The supernatant was 
added with 600 µl absolute ethanol, spiked-in with 2 µl of ath-
miR-159a mimic as an exogenous control and mixed vigorously 
for 10 seconds. Then, 600 µl of the mixture was transferred into a 
Spin Filter with a 2.0 ml receiver tube and centrifuged at 10.000 × 
g for 1 minute. The receiver tube was discarded with the filtrate and 
placed the Spin Filter into a new 2.0 ml receiver tube. The Spin 
Filter was subjected to washing steps with 500 µl of Washing 
Solution C, 650 µl of Washing Solution BS and 650 µl of absolute 
ethanol with centrifugation at 10.000 × g for 1 minute for each 
washing step. Then, the Spin Filter was centrifuged at maximum 
speed for 3 minutes to remove all traces of ethanol. Finally, the 
sample was eluted by adding 50 µl RNase-free water into the Spin 
Filter with a 1.5 ml Elution Tube, incubated at room temperature 
for 1 minutes and centrifuged at 10.000 × g for 1 minute. RNA 
yield and purity assessment was performed using NanoDrop® ND-
1000 spectrophotometer (Thermo Scientific, USA). Finally, the 
total RNA extract was stored at -80°C prior to usage. 
 
Reverse transcription 
 
Reverse transcription (RT) has been carried out on the total RNA 
extract using the miScript II RT Kit (Qiagen, Germany) according 
to the manufacturer’s protocol. The initial concentration of RNA 
template was standardized to 50 ng/µl for all samples. Preparation 
of master mix for each sample was performed by mixing 4 µl 4× 
miScript HiSpec Buffer, 2 µl 10x miScript Nucleics Mix, 2 µl 
miScript Reverse Transcriptase Mix & RNase-free water to make 
up the total reaction volume to 20 µl. The reaction master mix was 
incubated at 37°C for 60 minutes, followed by 95°C for 5 minutes 
and immediately cooled down to 4°C using CFX96 Touch™ Real-
Characteristics Number 
 
Gender  
         Man 
Age 
 
Year, median (range)  
 
Race 
 
       Malay 
 
 
                           5 
 
51 (16 – 70 years old) 
 
 
 
5 
MJBMB, 2019, 2, 60 - 63 
- 62 - 
 
Time PCR Detection System (Bio-Rad, USA). Then, the cDNA 
product was diluted into 200 µl of RNase-free water prior to 
qPCR procedure. 
 
Quantitative Polymerase Chain Reaction 
 
The qPCR has been performed using miScript SYBR Green PCR 
kit (Qiagen, Germany) and miScript Primer Aassay (Qiagen, 
Germany) of hsa-miR-101-3p as a primer of interest, SNORD48 as 
endogenous control and ath-miR-159a as an exogenous control. 
The reaction mixture for each sample was prepared by mixing 2.5 
μl of cDNA with 12.5 μl 2× QuantiTect SYBR Green PCR Master 
Mix, 2.5 μl 10× miScript Universal Primer, 2.5 μl 10× miScript 
Primer Assay and 5 μl RNase-free water. Each sample was 
prepared with triplicate. The sample has been amplified at 95°C 
for 15 minutes, 94°C for 15 seconds, 55°C for 30 seconds and 
70°C for 30 seconds for 40 cycles using CFX96 Touch™ Real-
Time PCR Detection System (Bio-Rad, USA). Then, the 
differential expression of miR-101 was calculated using 2-ΔΔCt 
method (7). 
 
Statistical analysis 
 
Statistical analysis was performed by using SPSS software version 
22.0.1. The Mann-Whitney U test was used to compare the mean 
between NPC and normal samples. 
 
RESULTS AND DISCUSSION 
 
Histopathological examination 
 
The histological sections have been examined by a highly trained 
pathologist using the light microscope. The NPC tissues have been 
examined for features of malignancy, while for normal tissues 
they have been examined to ascertain that the tissue is normal i.e. 
absence of tumor tissue. After the histological verification, the 
samples have been classified according to their respective 
grouping as in Table 2. However, two NPC samples have no their 
counterpart normal samples, which were NC 13 and NC 15. The 
histopathological examination found that out of eight nasopharynx 
biopsy samples, five samples have been confirmed as NPC and 
three samples have been confirmed as normal nasopharyngeal 
epithelium. The results were illustrated in Table 2 and Figure 1. 
 
Table 2. Status of histologically verified tissues 
 
 
 
 
 
 
 
 
 
 
 
Total RNA purity and yield 
 
The total RNA yield and purity have been determined by 
observing the absorbance ratio reading at for A260/280 and 
A260/230 as illustrated in Table 3. The ratio of A260/280 indicates 
the protein contamination of a nucleic acid sample. For pure 
nucleotide ratio, A260/280 ratio should be in the range of 1.8-2.0. 
A lower ratio indicates the sample is protein contaminated. The 
presence of protein contamination may affect the downstream 
applications. The A260/230 ratio indicates the presence of organic 
contaminants, such as phenol, chaotropic salts and aromatic 
compounds. Samples with A260/230 ratios below 2.0 were 
considered to have a significant amount of these contaminants that 
will interfere with downstream applications. Table 3 showed the 
purity and yield of our total RNA extraction. The RNA purity 
showed a reliable range of reading for downstream application. 
However, only one sample showed poor reading of A260/230 ratio, 
which was NN13, that indicated the presence of organic 
contaminants and this sample has been excluded from further 
analysis. Meanwhile, the rest of the samples showed the good 
purity to be eligible for downstream procedures. Our result showed 
that there was no issue regarding poor total RNA recovery due to 
formalin-induced cross-linking and degradation in FFPE samples, 
as mentioned previously, by using innuPREP FFPE Total RNA 
Kit (Analytik Jena, Germany) for total RNA isolation [8,9]. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1. Representative histologic sections for NPC of sample (A) NN 9, 
(B) NN10 and (C) NN 15 (Type of specimen: nasopharynx, original 
magnification:×40, stain: H&E). 
 
 
Table 3. The readings of total RNA yield, purity and contaminants in 
different tissue samples 
 
 
Differential expression of miR-101 
 
qPCR is one of the gold standards for quantifying gene expression. 
The sensitivity and specificity in measuring gene expression, even 
at low RNA quantity, make qPCR is largely selected for analysis 
[10]. Our analysis showed that miR-101 has been down-regulated 
in NPC as compared to normal nasopharyngeal epithelium 
Samples Type 
NC 9 Normal 
NN 9 NPC 
NC 10 NPC 
NN 10 NPC 
NC 11 Normal 
NN 11 
NN 13 
NN 15 
Normal 
NPC 
NPC 
Sample Type A260/A280 A260/A230 ng/µl 
NC 9 Normal 2.12 2.2 28.57 
NN 9 NPC 2.00 1.86 143.23 
NC 10 NPC 2.12 2.49 76.82 
NN 10 NPC 2.18 2.92 43.18 
NC 11 Normal 2.09 3.35 5.42 
NN 11 Normal 1.91 3.29 38.53 
NN 13 NPC 2.82 -1.53 4.75 
NN 15 NPC 2.04 2.41 88.95 
MJBMB, 2019, 2, 60 - 63 
- 63 - 
 
samples. However, the statistical analysis using Mann- Whitney U 
test demonstrated that there was no significant difference between 
miR-101 expression in NPC as compared normal nasopharyngeal 
epithelium samples (p=0.23), as illustrated in Figure 2. 
Interestingly, the down-regulation of miR-101 expression in NPC 
tissue as compared to normal nasopharyngeal epithelium tissue in 
our study was consistent with earlier study by Nurul-Syakima et al. 
[6]. The down-regulation of miR-101 in NPC, either in clinical 
samples or cell lines, also has been reported in previous studies, 
which supporting our finding, even with small sample size [11 – 
13]. Our differential expression results indicate the potential of 
miR-101 to be further studied comprehensively on its utilization as 
a biomarker for NPC. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2. Relative quantification of miR-101 in normal nasopharyngeal 
epithelium tissues and NPC tissues 
 
 
For future study, certain improvement must be made to obtain a 
more reliable and valid result. The use of precise sectioning 
instrument, such as microdissection, might reduce the surround 
non- cancerous tissues from being included in the extraction 
procedure, thus, giving a more accurate picture of miRNA 
quantification. Furthermore, increasing the small sample size 
could give more significant and valid result to reject the null 
hypothesis. 
 
CONCLUSION 
 
We have successfully showed that miRNA can be quantified from 
FFPE samples. We also demonstrated that the extracted miR-101 
from FFPE samples was consistent with previous studies, indicating 
the potential of miR-101 to be further studied for NPC. However, 
certain improvements are warranted to increase the significance 
and reliability of the result. 
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